This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Urinary Antibacterial And Antiseptic Pharmaceuticals Market

Market Insights on Urinary Antibacterial And Antiseptic Pharmaceuticals covering sales outlook, demand forecast & up-to-date key trends

Urinary Antibacterial And Antiseptic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2022-2032

Urinary Antibacterial And Antiseptic Pharmaceuticals Market Outlook

The urinary antibacterial and antiseptic pharmaceuticals market is likely to register a CAGR of 4.3% during the forecast period. The market is estimated to be valued at US$ 44.2 Bn in 2022 and likely to be valued at US$ 67.34 Bn by 2032.

Urinary Antibacterial and Antiseptic Pharmaceuticals Market CAGR (2022-2032)

4.3%

Urinary Antibacterial and Antiseptic Pharmaceuticals Market Value (2022)

US$ 44.2 Bn

Urinary Antibacterial and Antiseptic Pharmaceuticals Market Value (2032)

US$ 67.34 Bn

The growing urinary infections in the areas such as the urethra, bladder, kidney, and ureters are likely to upsurge the urinary antibacterial and antiseptic pharmaceuticals market size during the forecast period. Moreover, the rising population of diabetics, urinary catheters, and generic populations are likely to increase the adoption of urinary antibacterial and antiseptic pharmaceuticals during the forecast period.

E. coli and S. aureus are the causes of urinary infections, and the growth of these infections is likely to surge the market growth in recent years. The adoption of urinary antibacterial drugs such as penicillin, ciprofloxacin, and others is likely to flourish the demand for urinary antibacterial and antiseptic pharmaceuticals during the foreseen time.

However, the urinary antibacterial and antiseptic pharmaceutical treatment depend on the patient's health, history, and types of infectious bacteria. According to NIH, urinary tract infection is the most common infection, and nearly 8.1 million patients have been suffering globally in recent years. These patients are consulting with a physician, which is likely to increase the urinary antibacterial and antiseptic pharmaceuticals market growth. According to the Centers for Disease Control and Prevention report, patients suffering from urinary tract infections are acquired in 75% of hospitals globally.

Based on product type, the market is further categorized into antibacterial and antiseptic during the forecast period. However, the antibacterial product is likely to dominate the global market share by registering a significant share as it has been the primary treatment for urinary tract infections in recent years.

Based on distribution channels, the market is subdivided into hospital pharmacies, e-commerce, and pharmacy & drugstores during the foreseen time. In these, hospital pharmacies dominate the global market by capturing a higher share during the forecast period.

Based on region, Europe is estimated to lead the urinary antibacterial and antiseptic pharmaceuticals market by securing a relevant share during the forecast period. On the other hand, the prominent players are making efforts to develop the best antibiotics for urine infection and urinary antiseptic drugs to help patients recover fast in the region.

Customize this Report

Let us know your requirement to get
100% FREE customization

Reliance on R&D Activities to Grow

The R&D activities and rising healthcare specialists are likely to propel the market size in recent years. The key vendors are making several marketing methodologies to acquire the maximum share of the market, such as mergers, acquisitions, collaborations, and product launches.

Urinary tract infection refers to bacterial infection in any part of urinary system such as urethra, ureters, bladder and kidney. Urinary tract infections are common in patients which are using urinary catheter, diabetics and elderly people having compromised immunity.

Most of the urinary infections are caused by E. coli and S. aureus. Urinary tract infections are mostly treated with antibacterial drugs such as ciprofloxacin, azithromycin, penicillin and others. Urinary antiseptics such as nalidixic acid, nitrofurantoin etc.

can also be effectively used for management of urinary tract infections, these are the drugs which are excreted in urine and show their antiseptic action in the bladder. The choice of treatment depends on type of infectious bacteria and patient history, complicated urinary tract infections leads to kidney damage and may need hospitalization.

According to National Institute of Diabetes, Digestive and Kidney Diseases (NIH), urinary tract infection is the second most common type of infection and approximately 8.1 Mn patients visit every year to their physician concerning urinary tract infection.

Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Drivers and Restraints

Increasing recurrence rate for urinary tract infections is the major driver for the growth of urinary antibacterial and antiseptic pharmaceuticals market. Other factors influencing growth of urinary antibacterial and antiseptic pharmaceuticals market can be increasing incidence of diabetes, rising cases of catheter-associated urinary tract infections and expanding indications of drugs, availability of combination products, etc.

According to Center for Disease Control and Prevention (CDC), 75% of the hospital acquired urinary tract infections are associated with the catheter use. Major restraint for growth of global market for urinary antibacterial and antiseptic pharmaceuticals is increasing bacterial resistance to antibiotics.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Urinary Antibacterial and Antiseptic Pharmaceuticals Market Overview

The global urinary antibacterial and antiseptic pharmaceuticals market is expected to witness sluggish growth due to huge competition between generic players in major markets. Antibacterial product segment is anticipated to hold maximum market as it is the first line treatment for urinary tract infections.

Hospital end user segment will continue to lead the global market for urinary antibacterial and antiseptic pharmaceuticals market due to increasing usage of urinary catheters among patients. According to CDC data, 15-25% of all hospitalized patients require catheter use during their hospital stay.

Several new treatment options such as monoclonal antibodies are being developed for infection which can influence the market.

Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Region-wise Outlook

Geographically, the global urinary antibacterial and antiseptic pharmaceuticals market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.

Europe is anticipated to lead the global market for urinary antibacterial and antiseptic pharmaceutical due to greater incidence community acquired urinary tract infections, followed by North America. However, the market is expected to register decline in revenue in the regions of North America and Europe.

The Asia Pacific market for urinary antibacterial and antiseptic pharmaceuticals is anticipated to exhibit moderate growth.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Key Players

Some of the key market players in global urinary and antiseptic pharmaceuticals market are Pfizer Inc., AstraZeneca Plc., Merck & Co., GlaxoSmithKline Plc., Bayer Pharma AG, Johnson & Johnson Private Limited, Daiichi Sankyo Company Limited and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Segmentation

The global urinary antibacterial and antiseptic pharmaceuticals market is classified on the basis of product type, distribution channel and geography.

Based on product type, the global urinary antibacterial and antiseptic pharmaceuticals market is segmented as follows:

  • Antibacterial
  • Antiseptic

Based on distribution channel, the global urinary antibacterial and antiseptic pharmaceuticals market has been segmented as follows:

  • Hospital pharmacies
  • Pharmacy & Drugstores
  • E-commerce

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Urinary Antibacterial And Antiseptic Pharmaceuticals Market